Analysts debate Amazon's healthcare intentions — 5 insights

Written by Eric Oliver | October 30, 2017 | Print  |

Amazon is debating making a move into the healthcare arena, CNBC reports.

Here's what you should know:

1. The online sales giant recently registered the domain, but analysts are debating the company's intent.

2. Jefferies analysts Brian Tanquilut believes Amazon could enter the medical device business, while Wells Fargo speculates the company will sell pharmaceuticals.

3. Mr. Tanquilut examined a license granted in Nevada. On it, Amazon didn't disclose it would handle controlled substances. Although there are prescriptions that are uncontrolled, Mr. Tanquilut believes it represents a move towards medical devices.

4. Amazon posted a business-to-business medical device web page around the same time the company was awarded wholesale distribution licenses in several U.S. states.

5. Amazon told CNBC the company doesn't, "comment on rumors or speculation."

More articles on supply chain:
Dr. M. Jonathan Worsey earns national supply chain award — 4 insights
FDA creates medical device development tool program to speed up evaluation, approval process — 4 insights
Hurricanes Irma, Maria could create medical device shortages — 6 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.